Quotient Wealth Partners LLC Acquires 63 Shares of Cigna Group $CI

Quotient Wealth Partners LLC raised its holdings in Cigna Group (NYSE:CI) by 7.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 931 shares of the health services provider’s stock after acquiring an additional 63 shares during the period. Quotient Wealth Partners LLC’s holdings in Cigna Group were worth $308,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CI. Flaharty Asset Management LLC bought a new position in Cigna Group in the first quarter valued at about $28,000. 1248 Management LLC acquired a new stake in shares of Cigna Group during the first quarter valued at about $29,000. Activest Wealth Management boosted its stake in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC boosted its stake in shares of Cigna Group by 74.1% during the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 43 shares in the last quarter. Finally, Saudi Central Bank acquired a new stake in shares of Cigna Group during the first quarter valued at about $36,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Cigna Group stock opened at $299.81 on Friday. The stock’s 50 day moving average is $297.27 and its 200 day moving average is $308.13. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The firm has a market cap of $80.03 billion, a P/E ratio of 16.37, a P/E/G ratio of 0.88 and a beta of 0.45. Cigna Group has a one year low of $256.89 and a one year high of $353.55.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same period in the previous year, the firm earned $6.72 earnings per share. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group’s payout ratio is 32.97%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CI. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research note on Wednesday, October 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $365.00 price target on shares of Cigna Group in a research note on Tuesday, August 26th. Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday. Wells Fargo & Company lifted their price target on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $369.89.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.